decisionhealth Newsletters, decisionhealth - 2009 Issue 2 (February)
Stem Cell Harvesting / More Medicare coverage transmittals
Subscribe or sign in to view the full article.
Article Overview
This premium article reviews Medicare coverage transmittals and national coverage determination language related to stem cell harvesting and transplantation. It is aimed at coders, billers, and compliance staff who need to understand the scope of Medicare coverage, the affected clinical categories, and the policy references tied to the guidance. The article organizes coverage and noncoverage information by transplant type and diagnosis groupings, with supporting CMS and effective-date references.
Why This Topic Matters
Understanding whether a stem cell transplantation service falls within Medicare coverage policy affects claim preparation, reimbursement review, and compliance workflows. The article helps readers identify the policy framework and the diagnosis categories addressed by the coverage guidance.
Article Sections
-
CMS Manual System and change request references
Introduces the Medicare policy source material and effective-date references that frame the coverage discussion. It identifies the CMS documents and transmittal context discussed in the article.
-
Autologous stem cell transplantation: covered conditions
Summarizes the general covered-condition framework for autologous transplant services under Medicare. The section groups the relevant diagnosis categories and notes the policy timing context.
-
Additional effective-date guidance for multiple myeloma and amyloidosis
Addresses later coverage timing considerations that affect selected diagnoses within the autologous transplant policy. It includes age- and documentation-related policy context.
-
Noncovered conditions for autologous stem cell transplantation
Outlines the major categories described as not covered under Medicare for autologous transplant services. The section presents the broad diagnostic groupings referenced in the policy.
-
Allogeneic stem cell transplantation: covered and not covered conditions
Summarizes the Medicare coverage categories for allogeneic transplant services and identifies the diagnosis groupings discussed in the policy. It also notes the separate noncovered diagnosis area referenced by the article.
-
Autologous stem cell transplantation: diagnosis categories listed as covered and not covered
Provides a broader diagnosis-based summary of the autologous transplant policy, including the categories Medicare recognizes as covered and those described as noncovered. The section includes the article’s explanatory notes tied to those groupings.
What You Will Learn
- How the article frames Medicare policy references for stem cell transplantation
- Which transplant categories are discussed in relation to coverage status
- What types of diagnosis groupings are used to organize covered and noncovered policy language
- How effective dates and documentation context are presented in the article
- Which CMS documents and coverage sources are cited in the policy discussion
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Compliance professionals
- Utilization review staff
- Healthcare administrators
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com